[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100654651":3},{"organization":4,"outcomesModule":7,"designInfo":13,"detailedDescription":11,"studyPopulation":11,"armGroups":21,"interventions":32,"overallOfficials":11,"centralContacts":42,"locations":48,"responsibleParty":65,"collaborators":11,"id":69,"slug":70,"hasResults":71,"nctId":72,"briefTitle":73,"officialTitle":74,"acronym":75,"eligibilityCriteria":76,"healthyVolunteers":71,"sex":77,"minAge":78,"maxAge":11,"enrollmentInfo":79,"targetDuration":11,"studyType":82,"phases":83,"briefSummary":85,"conditions":86,"keywords":88,"overallStatus":51,"whyStopped":11,"lastUpdateSubmitDate":90,"lastUpdatePostDateStruct":91,"startDateStruct":94,"completionDateStruct":96,"leadSponsor":98,"locationsCount":99},{"fullName":5,"class":6},"Istanbul University","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":11,"otherOutcomes":11},[9],{"measure":10,"description":11,"timeFrame":12},"Locally Recurrance",null,"The first five years after enrollment.",{"allocation":14,"interventionModel":15,"interventionModelDescription":11,"primaryPurpose":16,"observationalModel":11,"timePerspective":11,"maskingInfo":17},"RANDOMIZED","SINGLE_GROUP","TREATMENT",{"masking":18,"maskingDescription":11,"whoMasked":19},"SINGLE",[20],"OUTCOMES_ASSESSOR",[22,27],{"label":23,"type":24,"description":11,"interventionNames":25},"Upfront Surgery","ACTIVE_COMPARATOR",[26],"Procedure: surgery",{"label":28,"type":29,"description":11,"interventionNames":30},"Neoadjuvant Radiotherapy Followed by Surgery","EXPERIMENTAL",[31,26],"Radiation: radiotherapy",[33,38],{"type":34,"name":35,"description":36,"armGroupLabels":37,"otherNames":11},"RADIATION","radiotherapy","Neoadjuvant Radiotherapy",[28],{"type":39,"name":40,"description":23,"armGroupLabels":41,"otherNames":11},"PROCEDURE","surgery",[28,23],[43],{"name":44,"role":45,"phone":46,"phoneExt":11,"email":47},"Baki Aydınlı","CONTACT","+9002124142000","drbakiaydinli@gmail.com",[49],{"facility":50,"status":51,"city":52,"state":11,"zip":11,"country":53,"countryCode":11,"cosmosGeoPoint":54,"geoPoint":59,"contacts":60},"İstanbul Univercity Faculty of Medicine","RECRUITING","Istanbul","Turkey (Türkiye)",{"type":55,"coordinates":56},"Point",[57,58],28.94966,41.01384,{"lat":58,"lon":57},[61],{"name":62,"role":45,"phone":63,"phoneExt":11,"email":64},"Cemil Burak Kulle","+900124142000","cemilburakkulle@gmail.com",{"type":66,"investigatorFullName":67,"investigatorTitle":68,"investigatorAffiliation":5,"oldNameTitle":11,"oldOrganization":11},"PRINCIPAL_INVESTIGATOR","Baki Aydinli","medical doctor","100654651","neoadjuvant-radiotherapy-vs-upfront-surgery-in-locally-advanced-proximal-rectal-cancer-100654651",false,"NCT07802197","Neoadjuvant Radiotherapy vs Upfront Surgery in Locally Advanced Proximal Rectal Cancer","The PRELUDE Study: A Prospective Cohort Study Comparing Neoadjuvant Radiotherapy Followed by Total Mesorectal Excision Versus Upfront Surgery in Patients With Locally Advanced Proximal Rectal Cancer","PRELUDE","Inclusion Criteria:\n\n* Locally Advanced Proximally Rectal Cancer\n\nExclusion Criteria:\n\n* Distant metastasis","ALL","18 Years",{"count":80,"type":81},100,"ESTIMATED","INTERVENTIONAL",[84],"NA","The PRELUDE Study: A Prospective Cohort Study Comparing Neoadjuvant Radiotherapy Followed by Total Mesorectal Excision Versus Upfront Surgery in Patients with Locally Advanced Proximal Rectal Cancer\n\nThe PRELUDE Study is a single-center, prospective cohort study designed to compare neoadjuvant radiotherapy followed by total mesorectal excision (TME) with upfront surgery alone in patients with locally advanced proximal rectal cancer.\n\nThe primary endpoint is the rate of local recurrence. Secondary endpoints include overall survival, disease-free survival, and functional outcomes related to bowel, urinary, and sexual function.\n\nThe aim of this study is to determine whether neoadjuvant radiotherapy reduces the risk of local recurrence and improves long-term oncological and functional outcomes in this anatomically distinct subgroup of patients with rectal cancer.",[87],"Rectal Adenocarcinoma",[89],"Rectal Cancer, Neoadjuvant Radiotherapy, Upfront Surgery","2026-09-02",{"date":92,"type":93},"2026-09-03","ACTUAL",{"date":95,"type":93},"2026-04-06",{"date":97,"type":81},"2031-12-01",{"name":5,"class":6},1]